Martine Chamuleau

DR.

1991 …2019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Open Access

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: Results from the CAVALLI phase 1b trial

Zelenetz, A. D., Salles, G., Mason, K. D., Casulo, C., le Gouill, S., Sehn, L. H., Tilly, H., Cartron, G., Chamuleau, M. E. D., Goy, A., Tam, C. S., Lugtenburg, P. J., Petrich, A. M., Sinha, A., Samineni, D., Herter, S., Ingalla, E., Szafer-Glusman, E., Klein, C., Sampath, D. & 3 othersKornacker, M., Mobasher, M. & Morschhauser, F., 2019, In : Blood. 133, 18, p. 1964-1976

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies

Kater, A. P., Tonino, S. H., Spiering, M., Chamuleau, M. E. D., Liu, R., Adewoye, A. H., Gao, J., Dreiling, L., Xin, Y., Doorduijn, J. K. & Kersten, M. J., 2018, In : Blood cancer journal. 8, 2, 16.

Research output: Contribution to journalComment/Letter to the editorAcademic

Interobserver variation in CD30 immunohistochemistry interpretation; consequences for patient selection for targeted treatment

Koens, L., van de Ven, P. M., Hijmering, N. J., Kersten, M. J., Diepstra, A., Chamuleau, M. & de Jong, D., 1 Sep 2018, In : Histopathology. 73, 3, p. 473-482 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access